$FLDD
FTAC Emerald Acquisition Corp. Stock $fldd

$fldd Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023024158 Filed on March 29, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$458.1K	$1.777M
YoY Change	356.65%	1667.7%
Operating Profit		-$1.777M
YoY Change
Interest Expense	$2.122M	$3.619M
YoY Change	400232.08%	682741.51%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$1.664M	$1.842M
YoY Change	-1767.35%	-1942.36%
Income Tax	$462.4K	$726.4K
% Of Pretax Income	27.79%	39.43%
Net Earnings	$1.201M	$1.116M
YoY Change	-1303.93%	-1215.88%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.03	$0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.75K	$72.75K
YoY Change	-94.08%	-94.08%
Cash & Equivalents	$72.75K
Short-Term Investments
Other Short-Term Assets	$185.2K	$185.2K
YoY Change	-54.98%	-54.98%
Inventory
Prepaid Expenses	$185.2K
Receivables
Other Receivables
Total Short-Term Assets	$258.0K	$258.0K
YoY Change	-84.26%	-84.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$254.3M	$254.3M
YoY Change	14.42%	14.42%
Other Assets
YoY Change
Total Long-Term Assets	$255.4M	$255.4M
YoY Change	14.26%	14.26%
TOTAL ASSETS
Total Short-Term Assets	$258.0K	$258.0K
Total Long-Term Assets	$255.4M	$255.4M
Total Assets	$255.7M	$255.7M
YoY Change	13.54%	13.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$111.1K	$111.1K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$21.54K	$21.54K
YoY Change	30.94%	30.94%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$492.0K	$492.0K
YoY Change	425.75%	425.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$9.859M	$9.859M
YoY Change	11.34%	11.34%
Total Long-Term Liabilities	$9.859M	$9.859M
YoY Change	11.34%	11.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$492.0K	$492.0K
Total Long-Term Liabilities	$9.859M	$9.859M
Total Liabilities	$10.35M	$10.35M
YoY Change	15.68%	15.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.502M
YoY Change	42.18%
Common Stock	$98.00
YoY Change	10.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.501M	$245.3M
YoY Change
Total Liabilities & Shareholders Equity	$255.7M	$255.7M
YoY Change	13.54%	13.54%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$1.201M	$1.116M
YoY Change	-1303.93%	-1215.88%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$629.1K	-$1.703M
YoY Change	6.0%	187.03%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$310.9K	-$28.43M
YoY Change	-100.14%	-87.2%
Cash From Investing Activities	$310.9K	-$28.43M
YoY Change	-100.14%	-87.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$28.98M
YoY Change	-100.0%	-87.06%
NET CHANGE
Cash From Operating Activities	-629.1K	-$1.703M
Cash From Investing Activities	310.9K	-$28.43M
Cash From Financing Activities	0.000	$28.98M
Net Change In Cash	-318.2K	-$1.155M
YoY Change	-126.45%	-194.08%
FREE CASH FLOW
Cash From Operating Activities	-$629.1K	-$1.703M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41168
CY2022	dei	Entity Registrant Name EntityRegistrantName	FTAC EMERALD ACQUISITION CORP.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2170416
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	2929 Arch Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1703
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Philadelphia
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19104
CY2022	dei	City Area Code CityAreaCode	(215)
CY2022	dei	Local Phone Number LocalPhoneNumber	701-9555
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	EMLD
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	243000000	usd
CY2022	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2022	dei	Auditor Location AuditorLocation	New York
CY2022	dei	Auditor Firm AuditorFirmId	100
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	72753	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1227914	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	185213	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	411358	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	257966	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1639272	usd
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	175362	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	1155000	usd
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	1155000	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	254251750	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	222200530	usd
CY2022Q4	us-gaap	Assets Assets	255664716	usd
CY2021Q4	us-gaap	Assets Assets	225170164	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	111063	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	77131	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	21535	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	16451	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	359410	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	492008	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	93582	usd
CY2022Q4	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount	8704270	usd
CY2021Q4	emld	Deferred Underwriters Discount DeferredUnderwritersDiscount	7700000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1155000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	10351278	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8948582	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	253814255	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	222200000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	98	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	89	usd
CY2022Q4	emld	Common Stock Value One CommonStockValueOne	861	usd
CY2021Q4	emld	Common Stock Value One CommonStockValueOne	876	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8501776	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5979383	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8500817	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5978418	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	255664716	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	225170164	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1776887	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	100518	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1776887	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-100518	usd
CY2022	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	3619061	usd
	us-gaap	Interest Income Securities Other Us Government InterestIncomeSecuritiesOtherUSGovernment	530	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1842174	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-99988	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	726410	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1115764	usd
	us-gaap	Net Income Loss NetIncomeLoss	-99988	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
	emld	Sale Of Private Placement Units SaleOfPrivatePlacementUnits	8900000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7362578	usd
	us-gaap	Net Income Loss NetIncomeLoss	-99988	usd
	emld	Accretion Of Common Stock Subject To Possible Redemption AccretionOfCommonStockSubjectToPossibleRedemption	-22166008	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-5978418	usd
CY2022	emld	Sale Of Private Placement Units In Overallotment SaleOfPrivatePlacementUnitsInOverallotment	860810	usd
CY2022	emld	Sale Of Public Warrants In Overallotment Net Of Offering Costs SaleOfPublicWarrantsInOverallotmentNetOfOfferingCosts	454360	usd
CY2022	emld	Accretion Of Common Stock Subject To Possible Redemption AccretionOfCommonStockSubjectToPossibleRedemption	-4953333	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1115764	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-8500817	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1115764	usd
	us-gaap	Net Income Loss NetIncomeLoss	-99988	usd
	emld	Formation Cost Paid By Sponsor FormationCostPaidBySponsor	208	usd
CY2022	us-gaap	Interest Income Securities Us Treasury InterestIncomeSecuritiesUSTreasury	3619061	usd
	us-gaap	Interest Income Securities Us Treasury InterestIncomeSecuritiesUSTreasury	530	usd
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-401507	usd
	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	586720	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33932	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	77131	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	5084	usd
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	16451	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	359410	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1703364	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-593448	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	28980354	usd
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	222200000	usd
CY2022	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund	548195	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28432159	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-222200000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	215600000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	28980362	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	8900000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	105260	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	398378	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28980362	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	224021362	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1155161	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1227914	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1227914	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	72753	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1227914	usd
CY2022	emld	Deferred Underwriting Payable Charged To Additional Paidin Capital DeferredUnderwritingPayableChargedToAdditionalPaidinCapital	1004270	usd
	emld	Deferred Underwriting Payable Charged To Additional Paidin Capital DeferredUnderwritingPayableChargedToAdditionalPaidinCapital	7700000	usd
	emld	Reimbursement Of Advisory Fee ReimbursementOfAdvisoryFee	1155000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	28693420	usd
CY2022Q4	emld	Transaction Costs TransactionCosts	14181568	usd
CY2022	emld	Underwriting Commissions UnderwritingCommissions	4973868	usd
CY2022	emld	Deferred Underwriting Fees DeferredUnderwritingFees	8704270	usd
CY2022	emld	Other Offering Costs OtherOfferingCosts	503430	usd
CY2022	emld	Fair Market Value Percentage FairMarketValuePercentage	0.80	pure
CY2022	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.50	pure
CY2022	emld	Public Offering Description PublicOfferingDescription	Following the closing of the Public Offering, the partial exercise of the over-allotment option, and the sale of the Private Placement Units, a total of $251,180,354 ($10.10 per Unit) was placed in a Trust Account (“Trust Account”). The proceeds are invested only in U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except for any interest income released to the Company to pay franchise and income taxes and up to $100,000 of interest to pay dissolution expenses, none of the funds held in trust will be released from the Trust Account until the earlier of (i) the consummation of the initial Business Combination; (ii) the redemption of the public shares if the Company is unable to consummate a Business Combination within 18 months from the completion of the Public Offering subject to applicable law, or 21 months from the closing of the Public Offering if the Company has executed a letter of intent, agreement in principle or definitive agreement for the initial Business Combination within 18 months from the closing of the Public Offering but has not completed the initial Business Combination within such 18-month period (the “Completion Window”); or (iii) the redemption of any public shares properly tendered in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company has not consummated the initial Business Combination within the Completion Window, or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public stockholders.
CY2022Q4	us-gaap	Cash Cash	72753	usd
CY2022Q4	emld	Working Capital workingCapital	203453	usd
CY2021Q4	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	105260	usd
CY2022	emld	Working Capital WorkingCapital	203453	usd
CY2022	emld	Emerging Growth Company Status EmergingGrowthCompanyStatus	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Emerging Growth Company</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash Cash	72753	usd
CY2021Q4	us-gaap	Cash Cash	1227914	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	254251750	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	222200530	usd
CY2022	emld	Incurred Offering Costs IncurredOfferingCosts	14181568	usd
CY2022	us-gaap	Payments For Commissions PaymentsForCommissions	4973868	usd
CY2022	us-gaap	Payments For Fees PaymentsForFees	8704270	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	503430	usd
	emld	Incurred Offering Costs IncurredOfferingCosts	12603430	usd
	us-gaap	Payments For Commissions PaymentsForCommissions	4400000	usd
	us-gaap	Payments For Fees PaymentsForFees	7700000	usd
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	503430	usd
CY2022	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	12922712	shares
CY2022	emld	Common Stock Subject To Possible Redemption commonStockSubjectToPossibleRedemption	24869342	shares
	emld	Common Stock Subject To Possible Redemption commonStockSubjectToPossibleRedemption	22000000	shares
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.3943	pure
	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. At December 31, 2022 and 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2022Q3	emld	Excise Tax Rate ExciseTaxRate	0.01	pure
CY2022Q3	emld	Fair Market Value Percentages FairMarketValuePercentages	0.01	pure
CY2022	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	Each Unit consists of one share of Class A common stock and one-half of one redeemable warrant (the “Public Warrants”).
CY2022	emld	Gross Proceeds GrossProceeds	248693420	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	8264360	usd
CY2022	emld	Class A Common Stock Issuance Costs ClassACommonStockIssuanceCosts	13734146	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	27119341	usd
CY2022Q4	emld	Class A Common Stock Subject To Possible Redemption ClassACommonStockSubjectToPossibleRedemption	253814255	usd
	emld	Gross Proceeds From Ipo GrossProceedsFromIPO	220000000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	7810000	usd
	emld	Class A Common Stock Issuance Costs ClassACommonStockIssuanceCosts	12156008	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	22166008	usd
CY2021Q4	emld	Class A Common Stock Subject To Possible Redemption ClassACommonStockSubjectToPossibleRedemption	222200000	usd
CY2021Q2	emld	Aggregate Price AggregatePrice	25000	usd
CY2021Q4	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On November 12, 2021, the Company effected a 0.9955-for-1.0 stock split, so that the Sponsor owns an aggregate of 8,763,333 Founder Shares.
CY2021Q4	emld	Founder Share FounderShare	8763333	shares
CY2022	emld	Founder Shares Description FounderSharesDescription	The Sponsor has agreed not to transfer, assign or sell any of its Founder Shares (i) with respect to 25% of such shares, until consummation of the initial Business Combination, (ii) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $12.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, (iii) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $13.50 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination, and (iv) with respect to 25% of such shares, until the earlier of the second anniversary of the consummation of the initial Business Combination or the first date at which the closing price of the Class A common stock exceeds $15.00 for any 20 trading days within a 30-trading day period following the consummation of the initial Business Combination.
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	300000	usd
CY2021Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	105260	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1500000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	30000	usd
CY2022	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	360000	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	16451	usd
CY2022Q4	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	16451	usd
CY2021Q4	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	16451	usd
CY2022	emld	Warrant Agreement Description WarrantAgreementDescription	The warrant agreement provides that the terms of the warrants may be amended without the consent of any stockholder or warrant holder to cure any ambiguity or correct any defective provision or to make any amendments that are necessary in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements, but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants. Accordingly, the Company may amend the terms of the public warrants (i) in a manner adverse to a holder of public warrants if holders of at least 50% of the then outstanding public warrants approve of such amendment or (ii) to the extent necessary for the warrants in the good faith determination of the board of directors of the Company (taking into account then existing market precedents) to allow for the warrants to continue to be classified as equity in the Company’s financial statements without the consent of any stockholder or warrant holder. Although the Company’s ability to amend the terms of the public warrants with the consent of at least 50% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or shares, shorten the exercise period or decrease the number of shares of Class A common stock purchasable upon exercise of a warrant.
CY2022	us-gaap	Underwriting Expense Ratio UnderwritingExpenseRatio	0.02	pure
CY2022	emld	Deferred Underwriting Discount DeferredUnderwritingDiscount	0.035	pure
CY2022	emld	Paid Ccm Fee Amount Equal Percentage PaidCcmFeeAmountEqualPercentage	0.003	pure
CY2022	emld	Advisory Fee Percentage advisoryFeePercentage	0.00525	pure
CY2022	emld	Financial Advisory Fee Description FinancialAdvisoryFeeDescription	The underwriter has agreed to reimburse the Company for the fee to CCM as it becomes payable out of the underwriting commission. Accordingly, a reimbursement receivable and deferred advisory fee of $1,155,000 has been reflected in the accompanying balance sheets.
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	emld	Public Warrant Shares PublicWarrantShares	11000000	shares
	emld	Private Warrant Shares PrivateWarrantShares	445000	shares
CY2022	emld	Public Warrant Shares PublicWarrantShares	12434671	shares
CY2022	emld	Private Warrant Shares PrivateWarrantShares	488041	shares
CY2022	emld	Description Of Exercise Price And Number Of Shares Of Common Stock DescriptionOfExercisePriceAndNumberOfSharesOfCommonStock	In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial stockholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
CY2022	emld	Sharebased Compensations Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2022	emld	Warrants For Redemption Description WarrantsForRedemptionDescription	Redemption of warrants Once the warrants become exercisable, the Company may redeem the outstanding warrants: ●in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption, or the 30-day redemption period, to each warrant holder; and ● if, and only if, the last sale price of the Class A common stock (or the closing bid price of the Class A common stock in the event the shares of Class A common stock are not traded on any specific trading day) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	254251750	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	222200530	usd
CY2022Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	350184	usd
CY2021Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	10144	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10853	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	350184	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20997	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	350184	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20997	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	726410	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	329186	usd
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	20997	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-329186	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-20997	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	726410	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21	usd
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21	usd
CY2022	emld	Change In Valuation Allowance ChangeInValuationAllowance	17.9	usd
	emld	Change In Valuation Allowance ChangeInValuationAllowance	-21	usd
CY2022	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	38.9	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent		usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022	emld	Formation Cost Paid By Sponsor FormationCostPaidBySponsor		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	us-gaap	Proceeds From Decommissioning Fund ProceedsFromDecommissioningFund		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
CY2022	emld	Reimbursement Of Advisory Fee ReimbursementOfAdvisoryFee		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001889123

Files In Submission

Name	View Source	Status
emld-20221231_def.xml	Edgar Link	unprocessable
0001213900-23-024158-index-headers.html	Edgar Link	pending
0001213900-23-024158-index.html	Edgar Link	pending
0001213900-23-024158.txt	Edgar Link	pending
0001213900-23-024158-xbrl.zip	Edgar Link	pending
emld-20221231.xsd	Edgar Link	pending
f10k2022ex21-1_ftacemerald.htm	Edgar Link	pending
f10k2022ex31-1_ftacemerald.htm	Edgar Link	pending
f10k2022ex31-2_ftacemerald.htm	Edgar Link	pending
f10k2022ex32-1_ftacemerald.htm	Edgar Link	pending
f10k2022ex32-2_ftacemerald.htm	Edgar Link	pending
f10k2022_ftacemerald.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
emld-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_ftacemerald_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
emld-20221231_cal.xml	Edgar Link	unprocessable
emld-20221231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FLDD
FTAC Emerald Acquisition Corp. Stock $fldd

2022 Q4 Form 10-K Financial Statement

#000121390023024158 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLDD FTAC Emerald Acquisition Corp. Stock $fldd

2022 Q4 Form 10-K Financial Statement

#000121390023024158 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FLDD
FTAC Emerald Acquisition Corp. Stock $fldd